SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs
Resolution: 2.7 Å
EM Method: Single-particle
Fitted PDBs: 8vye
Q-score: 0.433
Magaret CA, Li L, deCamp AC, Rolland M, Juraska M, Williamson BD, Ludwig J, Molitor C, Benkeser D, Luedtke A, Simpkins B, Heng F, Sun Y, Carpp LN, Bai H, Dearlove BL, Giorgi EE, Jongeneelen M, Brandenburg B, McCallum M, Bowen JE, Veesler D, Sadoff J, Gray GE, Roels S, Vandebosch A, Stieh DJ, Le Gars M, Vingerhoets J, Grinsztejn B, Goepfert PA, de Sousa LP, Silva MST, Casapia M, Losso MH, Little SJ, Gaur A, Bekker LG, Garrett N, Truyers C, Van Dromme I, Swann E, Marovich MA, Follmann D, Neuzil KM, Corey L, Greninger AL, Roychoudhury P, Hyrien O, Gilbert PB
Nat Commun (2024) 15 pp. 2175-2175 [ Pubmed: 38467646 DOI: doi:10.1038/s41467-024-46536-w ]
- Spike glycoprotein (140 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- S2l20 heavy chain (13 kDa, Protein from Homo sapiens)
- Sars-cov-2 s c.37 (lambda variant) plus s309, s2l20, and s2x303 fabs (Complex from Severe acute respiratory syndrome coronavirus 2)
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- S2l20 light chain (11 kDa, Protein from Homo sapiens)
- S2x303 heavy chain (13 kDa, Protein from Homo sapiens)
- S309 light chain (11 kDa, Protein from Homo sapiens)
- S309 heavy chain (14 kDa, Protein from Homo sapiens)
- S2x303 light chain (11 kDa, Protein from Homo sapiens)
SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement
Resolution: 3.2 Å
EM Method: Single-particle
Fitted PDBs: 8vyf
Q-score: 0.459
Magaret CA, Li L, deCamp AC, Rolland M, Juraska M, Williamson BD, Ludwig J, Molitor C, Benkeser D, Luedtke A, Simpkins B, Heng F, Sun Y, Carpp LN, Bai H, Dearlove BL, Giorgi EE, Jongeneelen M, Brandenburg B, McCallum M, Bowen JE, Veesler D, Sadoff J, Gray GE, Roels S, Vandebosch A, Stieh DJ, Le Gars M, Vingerhoets J, Grinsztejn B, Goepfert PA, de Sousa LP, Silva MST, Casapia M, Losso MH, Little SJ, Gaur A, Bekker LG, Garrett N, Truyers C, Van Dromme I, Swann E, Marovich MA, Follmann D, Neuzil KM, Corey L, Greninger AL, Roychoudhury P, Hyrien O, Gilbert PB
Nat Commun (2024) 15 pp. 2175-2175 [ Pubmed: 38467646 DOI: doi:10.1038/s41467-024-46536-w ]
- Spike glycoprotein (140 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- S2l20 heavy chain (13 kDa, Protein from Homo sapiens)
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- S2l20 light chain (11 kDa, Protein from Homo sapiens)
- Sars-cov-2 s c.37 (lambda variant) plus s309, s2l20, and s2x303 fabs. local refinement of ntd with s2l20 and s2x303 fabs. (Complex from Severe acute respiratory syndrome coronavirus 2)
- S2x303 heavy chain (13 kDa, Protein from Homo sapiens)
- S2x303 light chain (11 kDa, Protein from Homo sapiens)
SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement
Resolution: 3.1 Å
EM Method: Single-particle
Fitted PDBs: 8vyg
Q-score: 0.395
Magaret CA, Li L, deCamp AC, Rolland M, Juraska M, Williamson BD, Ludwig J, Molitor C, Benkeser D, Luedtke A, Simpkins B, Heng F, Sun Y, Carpp LN, Bai H, Dearlove BL, Giorgi EE, Jongeneelen M, Brandenburg B, McCallum M, Bowen JE, Veesler D, Sadoff J, Gray GE, Roels S, Vandebosch A, Stieh DJ, Le Gars M, Vingerhoets J, Grinsztejn B, Goepfert PA, de Sousa LP, Silva MST, Casapia M, Losso MH, Little SJ, Gaur A, Bekker LG, Garrett N, Truyers C, Van Dromme I, Swann E, Marovich MA, Follmann D, Neuzil KM, Corey L, Greninger AL, Roychoudhury P, Hyrien O, Gilbert PB
Nat Commun (2024) 15 pp. 2175-2175 [ Pubmed: 38467646 DOI: doi:10.1038/s41467-024-46536-w ]
- Spike glycoprotein (140 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- Sars-cov-2 s c.37 (lambda variant) plus s309, s2l20, and s2x303 fabs (Complex from Severe acute respiratory syndrome coronavirus 2)
- S309 light chain (11 kDa, Protein from Homo sapiens)
- S309 heavy chain (14 kDa, Protein from Homo sapiens)
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)